Naloxone prevents increased vascular sensitivity in goldblatt hypertensive rats

Min Chen, R Clinton Webb, Richard L. Malvin

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

These experiments were designed to determine if the opiate antagonist naloxone affects vascular sensitivity in 2K-1C hypertensive rats. Group 1 was 2K-1C hypertensive rats. Group 2 was 2K-1C rats given a naloxone infusion (100 μg/h) for 14 days. Group 3 received naloxone without clipping. Group 4 was untreated rats. At day 14 following clipping, systolic blood pressure was increased significantly in the 2K-1C rats. Those infused with naloxone showed a significant attenuation of the increase in blood pressure. Vascular responses to norepinephrine and KCI in the aortae from all groups were tested. Strips from untreated, 2K-1C rats were more sensitive to the contractile effects of norepinephrine than those from naloxonetreated, 2K-1C rats, and from both groups of normotensive rats. Contractile responsiveness to depolarizing concentrations of KCI were not different among the four groups. These data demonstrate that naloxone attenuates the development of renal hypertension and prevents the increase in vascular responsiveness to norepinephrine.

Original languageEnglish (US)
Pages (from-to)1361-1376
Number of pages16
JournalClinical and Experimental Hypertension
VolumeA12
Issue number8
DOIs
StatePublished - Jan 1 1990
Externally publishedYes

Fingerprint

Naloxone
Blood Vessels
Norepinephrine
Blood Pressure
Opiate Alkaloids
Renal Hypertension
Aorta

Keywords

  • Naloxone
  • Renal Hypertension
  • Vascular Sensitivity

ASJC Scopus subject areas

  • Internal Medicine
  • Physiology

Cite this

Naloxone prevents increased vascular sensitivity in goldblatt hypertensive rats. / Chen, Min; Webb, R Clinton; Malvin, Richard L.

In: Clinical and Experimental Hypertension, Vol. A12, No. 8, 01.01.1990, p. 1361-1376.

Research output: Contribution to journalArticle

@article{0495841a08c346c091e750fe4ab25c1b,
title = "Naloxone prevents increased vascular sensitivity in goldblatt hypertensive rats",
abstract = "These experiments were designed to determine if the opiate antagonist naloxone affects vascular sensitivity in 2K-1C hypertensive rats. Group 1 was 2K-1C hypertensive rats. Group 2 was 2K-1C rats given a naloxone infusion (100 μg/h) for 14 days. Group 3 received naloxone without clipping. Group 4 was untreated rats. At day 14 following clipping, systolic blood pressure was increased significantly in the 2K-1C rats. Those infused with naloxone showed a significant attenuation of the increase in blood pressure. Vascular responses to norepinephrine and KCI in the aortae from all groups were tested. Strips from untreated, 2K-1C rats were more sensitive to the contractile effects of norepinephrine than those from naloxonetreated, 2K-1C rats, and from both groups of normotensive rats. Contractile responsiveness to depolarizing concentrations of KCI were not different among the four groups. These data demonstrate that naloxone attenuates the development of renal hypertension and prevents the increase in vascular responsiveness to norepinephrine.",
keywords = "Naloxone, Renal Hypertension, Vascular Sensitivity",
author = "Min Chen and Webb, {R Clinton} and Malvin, {Richard L.}",
year = "1990",
month = "1",
day = "1",
doi = "10.3109/10641969009073524",
language = "English (US)",
volume = "A12",
pages = "1361--1376",
journal = "Clinical and Experimental Hypertension",
issn = "1064-1963",
publisher = "Informa Healthcare",
number = "8",

}

TY - JOUR

T1 - Naloxone prevents increased vascular sensitivity in goldblatt hypertensive rats

AU - Chen, Min

AU - Webb, R Clinton

AU - Malvin, Richard L.

PY - 1990/1/1

Y1 - 1990/1/1

N2 - These experiments were designed to determine if the opiate antagonist naloxone affects vascular sensitivity in 2K-1C hypertensive rats. Group 1 was 2K-1C hypertensive rats. Group 2 was 2K-1C rats given a naloxone infusion (100 μg/h) for 14 days. Group 3 received naloxone without clipping. Group 4 was untreated rats. At day 14 following clipping, systolic blood pressure was increased significantly in the 2K-1C rats. Those infused with naloxone showed a significant attenuation of the increase in blood pressure. Vascular responses to norepinephrine and KCI in the aortae from all groups were tested. Strips from untreated, 2K-1C rats were more sensitive to the contractile effects of norepinephrine than those from naloxonetreated, 2K-1C rats, and from both groups of normotensive rats. Contractile responsiveness to depolarizing concentrations of KCI were not different among the four groups. These data demonstrate that naloxone attenuates the development of renal hypertension and prevents the increase in vascular responsiveness to norepinephrine.

AB - These experiments were designed to determine if the opiate antagonist naloxone affects vascular sensitivity in 2K-1C hypertensive rats. Group 1 was 2K-1C hypertensive rats. Group 2 was 2K-1C rats given a naloxone infusion (100 μg/h) for 14 days. Group 3 received naloxone without clipping. Group 4 was untreated rats. At day 14 following clipping, systolic blood pressure was increased significantly in the 2K-1C rats. Those infused with naloxone showed a significant attenuation of the increase in blood pressure. Vascular responses to norepinephrine and KCI in the aortae from all groups were tested. Strips from untreated, 2K-1C rats were more sensitive to the contractile effects of norepinephrine than those from naloxonetreated, 2K-1C rats, and from both groups of normotensive rats. Contractile responsiveness to depolarizing concentrations of KCI were not different among the four groups. These data demonstrate that naloxone attenuates the development of renal hypertension and prevents the increase in vascular responsiveness to norepinephrine.

KW - Naloxone

KW - Renal Hypertension

KW - Vascular Sensitivity

UR - http://www.scopus.com/inward/record.url?scp=0025649736&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025649736&partnerID=8YFLogxK

U2 - 10.3109/10641969009073524

DO - 10.3109/10641969009073524

M3 - Article

AN - SCOPUS:0025649736

VL - A12

SP - 1361

EP - 1376

JO - Clinical and Experimental Hypertension

JF - Clinical and Experimental Hypertension

SN - 1064-1963

IS - 8

ER -